Form 8-K - Current report:
SEC Accession No. 0000950103-24-012639
Filing Date
2024-08-27
Accepted
2024-08-27 06:19:08
Documents
16
Period of Report
2024-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp217093_8k.htm   iXBRL 8-K 34038
2 EXHIBIT 10.1 dp217093_ex1001.htm EX-10.1 36912
3 EXHIBIT 99.1 dp217093_ex9901.htm EX-99.1 11276
7 GRAPHIC image_001.jpg GRAPHIC 2350
  Complete submission text file 0000950103-24-012639.txt   272269

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE endo-20240825.xsd EX-101.SCH 3003
5 XBRL LABEL FILE endo-20240825_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE endo-20240825_pre.xml EX-101.PRE 22351
18 EXTRACTED XBRL INSTANCE DOCUMENT dp217093_8k_htm.xml XML 3215
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 241243156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)